1.
Jonušaitė I, Giedraitienė N, Kaubrys G, Kizlaitienė R. The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab. NS. 2024;27(Nr. 3 (97):127-135. doi:10.29014/NS.2023.27.97.1